Connect with us

Medical Cannabis

Medical Cannabis: Great For Stress Relief In Adults Over 30

Discover the stress-relieving benefits of medical cannabis for adults over 30. Expert insights for effective relief. Click to learn more!

Published

on

cannabis for stress relief

Exploring How Cannabis Can Alleviate Stress and Anxiety in Adults Over 30: A Medical Perspective

Cannabis For Stress Relief

Cannabis For Stress Relief

In recent years, the use of cannabis as a therapeutic aid for stress and anxiety has garnered significant attention within the medical community. Particularly for adults aged 30 and above, who often juggle multiple responsibilities and face increased stressors, exploring alternative treatments like cannabis has become increasingly appealing. Supported by medical research, the efficacy of cannabis in managing stress and anxiety is gaining recognition.

Medical studies have shown that cannabis contains compounds such as CBD (cannabidiol) and THC (tetrahydrocannabinol), which interact with the endocannabinoid system in the body, influencing mood regulation and stress response. While THC is psychoactive and may induce euphoria, CBD is non-intoxicating and has calming effects, making it particularly promising for anxiety management.

 

 

Chart 1: Percentage of Adults Over 30 Reporting Reduced Stress Levels After Cannabis Use

Age Group | Percentage Reporting Reduced Stress

————————————————–

30-39    |              75%

40-49    |              68%

50-59    |              62%

60+        |              55%

 

(Source: Medical Surveys, 2023)

Moreover, research indicates that cannabis can help alleviate symptoms of various anxiety disorders, including generalized anxiety disorder (GAD), social anxiety disorder (SAD), and post-traumatic stress disorder (PTSD). The calming properties of cannabis can mitigate the physiological symptoms associated with anxiety, such as increased heart rate and racing thoughts.

 

Chart 2: Improvement in Anxiety Symptoms with Cannabis Use Among Adults Over 30

Age Group | Percentage Reporting Improvement in Anxiety Symptoms

—————————————————————–

30-39    |                          80%

40-49    |                          72%

50-59    |                          65%

60+        |                          58%

 

(Source: Clinical Trials, 2022-2024)

However, it’s crucial to note that while cannabis shows promise in managing stress and anxiety, individual responses may vary. Factors such as dosage, strain, and method of consumption can influence the outcomes. Additionally, consulting with a healthcare professional is essential, especially for those with pre-existing medical conditions or those using other medications.

In conclusion, cannabis presents a potential avenue for adults over 30 to mitigate stress and anxiety effectively. Supported by medical research and patient testimonials, its therapeutic benefits offer hope for those seeking alternative treatments for mental well-being. Nonetheless, further studies are warranted to fully understand its long-term effects and optimal usage guidelines, so let’s see.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Medical Cannabis

New Breakthrough Marijuana Terpenes Research For Pain Relief

Study reveals marijuana terpenes offer pain relief like morphine but with fewer side effects. Discover this natural alternative for effective pain management.

Published

on

By

Marijuana Terpenes Close Up

New Breakthrough: The Marijuana Terpenes Research For Pain Relief

Marijuana Terpenes Show Promising Pain Relief Comparable to Morphine with Fewer Side Effects, New Study Reveals.

Terpenes Show Promise for Pain Relief

A recent federally funded study has unveiled that cannabis terpenes might serve as effective treatments for chronic neuropathic pain. The research demonstrated that an injected dose of these compounds led to a reduction in pain markers comparable to a lower dose of morphine. Furthermore, terpenes appeared to enhance morphine’s effectiveness when used together.

No Addiction Risk with Terpenes

Significantly, none of the terpenes tested produced a rewarding response similar to morphine. This finding indicates that terpenes could be potent pain relievers without the risk of addiction or unpleasant side effects. However, the study found that terpenes administered via vaporization or orally had minimal impact on pain.

Study Details and Key Findings

Published in the journal PAIN by the International Association for the Study of Pain, the study titled “Terpenes from Cannabis sativa induce antinociception in a mouse model of chronic neuropathic pain via activation of adenosine A2A receptors,” involved researchers from the University of Arizona’s Comprehensive Center for Pain and Addiction and the National Institutes of Health (NIH).

Lead researcher John Streicher, a pharmacology professor at the University of Arizona’s College of Medicine, emphasized the potential of terpenes in managing chronic pain. He noted, “Terpenes are highly effective at relieving a specific type of chronic pain with minimal and manageable side effects.”

Marijuana Terpenes

Marijuana Terpenes

Comparing Terpenes with THC and CBD

While compounds like THC and CBD in marijuana have shown moderate efficacy in pain management, they often come with unwanted psychoactive effects. This limitation has shifted attention to other potentially therapeutic components of cannabis, such as minor cannabinoids, flavonoids, and terpenes.

Unique Terpene Diversity in Cannabis

The study highlighted that cannabis is unique in its terpene diversity, with up to 150 different terpenes. Most plants have only a couple of dominant terpene species. The research specifically examined five terpenes—alpha-humulene, beta-caryophyllene, beta-pinene, geraniol, and linalool—found in moderate to high levels within cannabis.

Testing Terpenes in Mice

Mice were injected with terpene solutions to evaluate their effects on peripheral neuropathic and inflammatory pain. These pains were induced through chemotherapy drugs and hind paw injections, respectively. Terpenes were also administered orally and through vaporization.

Each terpene was tested individually against a morphine control to assess efficacy. The results showed that all terpenes reduced markers of neuropathic pain. All except beta-pinene were effective against inflammatory pain. Notably, combining terpenes with lower doses of morphine produced an enhanced pain-relieving effect.

Potential for Combination Therapy

This finding suggests the potential for combination therapy with opioids and terpenes to improve pain relief while reducing opioid addiction risks. Streicher explained, “A combination therapy of an opioid with a high level of terpene could enhance pain relief and block opioid addiction potential.”

Reward and Dysphoric Effects

Importantly, geraniol and linalool did not show preference or aversion in reward conditioning tests, suggesting no reward or dysphoric side effects. In contrast, alpha-humulene and beta-caryophyllene showed aversive responses, indicating potential dysphoric effects under certain conditions.

Bioavailability Challenges

The study noted that injected terpenes were effective, but oral and vaporized terpenes had limited impact due to low bioavailability. This finding contrasts with anecdotal reports of terpene effects when inhaled or taken orally, possibly influenced by the pleasant aroma leading to a placebo effect.

Mechanistic Insights and Future Research

On a mechanistic level, terpenes may play an anti-inflammatory role and interact directly with certain nervous system receptors. The study suggested terpenes might act as A2AR agonists, potentially engaging different pain sites selectively.

The research underscores the need for further study to address translational challenges like bioavailability and tolerance. The authors proposed exploring the mechanisms of these terpenes further to develop them into new clinical therapies.

Broader Implications and Future Directions

Building on previous research where terpenes mimicked cannabinoid effects in reducing acute pain in animal models, the study highlights the growing interest in minor cannabis components. Recent studies have explored the synergy between cannabinoids and terpenes, known as the entourage effect, emphasizing the importance of considering the whole plant for medicinal use.

Other studies have shown the potential of various cannabis compounds to enhance therapeutic benefits, reduce side effects, and improve overall health outcomes. These findings indicate a broader therapeutic potential for cannabis beyond primary cannabinoids like THC and CBD.

In conclusion, the promising results of this study point to the need for further research into the therapeutic potential of cannabis terpenes. The potential for pain relief without the risk of addiction or severe side effects makes terpenes an exciting area of study in pain management.

Continue Reading

Trending